1. Home
  2. MYE vs GOSS Comparison

MYE vs GOSS Comparison

Compare MYE & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myers Industries Inc.

MYE

Myers Industries Inc.

HOLD

Current Price

$20.91

Market Cap

762.4M

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$2.48

Market Cap

615.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MYE
GOSS
Founded
1933
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
762.4M
615.7M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MYE
GOSS
Price
$20.91
$2.48
Analyst Decision
Buy
Strong Buy
Analyst Count
1
7
Target Price
$21.00
$8.83
AVG Volume (30 Days)
286.3K
4.7M
Earning Date
03-05-2026
03-12-2026
Dividend Yield
2.61%
N/A
EPS Growth
77.06
N/A
EPS
0.74
N/A
Revenue
$825,644,000.00
$44,051,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$0.98
$6.41
P/E Ratio
$28.00
N/A
Revenue Growth
0.26
N/A
52 Week Low
$9.06
$0.76
52 Week High
$20.81
$3.87

Technical Indicators

Market Signals
Indicator
MYE
GOSS
Relative Strength Index (RSI) 66.77 41.85
Support Level $19.83 $2.49
Resistance Level $20.81 $2.72
Average True Range (ATR) 0.53 0.21
MACD 0.03 -0.01
Stochastic Oscillator 83.24 27.25

Price Performance

Historical Comparison
MYE
GOSS

About MYE Myers Industries Inc.

Myers Industries Inc designs, manufactures, and markets a variety of plastic, metal, and rubber products, including a broad selection of plastic reusable containers, pallets, small parts bins, bulk shipping containers, storage and organization products, OEM parts, custom plastic products, consumer fuel containers and tanks for water, fuel and waste handling. It operates through the following segments: The Material Handling segment manufactures a selection of durable plastic reusable products that are used repeatedly during the course of their service life. The Distribution segment is engaged in the distribution of equipment, tools, and supplies used for tire servicing and automotive under-vehicle repair, etc. It generates the majority of its revenue from the Material Handling segment.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: